Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year Olds to Detect Atrial Fibrillation -STROKESTOP II

医学 心房颤动 随机对照试验 内科学 冲程(发动机) 入射(几何) 心脏病学 儿科 机械工程 光学 物理 工程类
作者
Katrin Kemp Gudmundsdottir,Emma Svennberg,Leif Friberg,Tove Hygrell,Viveka Frykman,Faris Al‐Khalili,Ziad Hijazi,Mårten Rosenqvist,Johan Engdahl
出处
期刊:Circulation [Lippincott Williams & Wilkins]
被引量:5
标识
DOI:10.1161/circulationaha.124.071176
摘要

Background: Guidelines have suggested screening for atrial fibrillation to enable early treatment and avoid downstream negative clinical events. We aimed to determine if atrial fibrillation screening potentially enhanced by NT-proBNP would reduce stroke or systemic embolism incidence as compared to in a control group and to determine if it was safe for those with low NT-proBNP concentrations to forfeit prolonged screening. Methods: In this randomized controlled trial all 75/76-year-old individuals in Stockholm Region, Sweden were randomized 1:1 to be invited to screening or serve as a control group. NT-proBNP concentration were measured and a single-lead-ECG registered only once if NT-proBNP<125ng/L, whereas if NT-proBNP≥125 ng/L participants underwent prolonged screening, recording single-lead ECGs four times daily for two weeks. If atrial fibrillation was detected, treatment was initiated. Baseline and outcome data were collected from Swedish National Registries. Results: In total 28,712 individuals were randomized, after exclusion of death and emigration 13,905 remained in the intervention group, 13,884 in the control group. Participation rate in the intervention group was 49.2% (6,843/13,905). Participants in the high NT-proBNP group (NT-proBNP≥125 ng/L) without prior atrial fibrillation constituted 60% of the total and underwent prolonged screening. New AF was detected in 2.4% (165/6,843) in the intervention group. There was no difference in AF prevalence or oral anticoagulant treatment between the intervention and the control group after five years follow-up. After a median of 5.1 years (IQR 5.0-5.8) there was no difference in the primary outcome of stroke or systemic embolism between the intervention group and the control group, HR: 0.96 (95% CI 0.86-1.06). The low NT-proBNP-group had significantly fewer strokes or systemic emboli than the control group, HR: 0.59 (95% CI 0.46-0.74), p<0.001. In the high NT-proBNP group the risk of stroke or systemic embolism was higher compared to the low NT-proBNP group, HR: 1.57 (95% CI 1.22-2.02), p=0.001. Conclusions: In this population-based screening trial for atrial fibrillation using NT-proBNP for screening enhancement, there was no difference in risk of stroke or systemic embolism for the intervention group compared to controls. Participation was moderate. The use of NT-proBNP for screening enhancement was safe in identifying low-risk participants. Clinical Trial Registration: www.clinicaltrials.gov; NCT02743416

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
WzJCW完成签到,获得积分20
刚刚
梦寐寤寐发布了新的文献求助10
刚刚
1秒前
王12完成签到,获得积分10
2秒前
2秒前
3秒前
3秒前
4秒前
skip发布了新的文献求助10
4秒前
4秒前
Ican发布了新的文献求助10
4秒前
4秒前
通过发布了新的文献求助10
5秒前
不安的问雁完成签到,获得积分20
5秒前
拜拜拜仁完成签到,获得积分10
5秒前
晨晨的应助被WSND采纳,获得50
7秒前
8秒前
9秒前
10秒前
orange发布了新的文献求助10
10秒前
10秒前
chris chen完成签到,获得积分10
10秒前
10秒前
哈哈哈哈发布了新的文献求助10
10秒前
beibei发布了新的文献求助10
10秒前
10秒前
11秒前
ying777完成签到,获得积分20
12秒前
12秒前
xl发布了新的文献求助10
13秒前
15秒前
充电宝的应助被ZB采纳,获得10
15秒前
16秒前
16秒前
Rina发布了新的文献求助10
16秒前
17秒前
JiaQi完成签到,获得积分10
18秒前
无敌黄金发布了新的文献求助10
19秒前
忆深完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192903
求助须知:如何正确求助?哪些是违规求助? 9579325
关于积分的说明 21864493
捐赠科研通 7792494
什么是DOI,文献DOI怎么找? 3437087
关于科研通互助平台的介绍 2560652
邀请新用户注册赠送积分活动 2483937